Report Detail

Pharma & Healthcare Global Pneumococcal Polysaccharide Vaccine Market Professional Survey Report 2019

  • RnM2816577
  • |
  • 04 October, 2019
  • |
  • Global
  • |
  • 103 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23. 

The global Pneumococcal Polysaccharide Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pneumococcal Polysaccharide Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Polysaccharide Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pneumococcal Polysaccharide Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pneumococcal Polysaccharide Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck & Co., Inc.
Pfizer Inc.
Glaxosmithkline Plc.
Sanofi Pasteur
China National Biotec Group
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Single Dose Vial
Pre-Filled Syringe

Segment by Application
Children (2-10 Age)
Adult (10-64 Age)
Geriatric (More Than 65 Age)


Table of Contents

    Executive Summary

      1 Industry Overview of Pneumococcal Polysaccharide Vaccine

      • 1.1 Definition of Pneumococcal Polysaccharide Vaccine
      • 1.2 Pneumococcal Polysaccharide Vaccine Segment by Type
        • 1.2.1 Global Pneumococcal Polysaccharide Vaccine Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Single Dose Vial
        • 1.2.3 Pre-Filled Syringe
      • 1.3 Pneumococcal Polysaccharide Vaccine Segment by Applications
        • 1.3.1 Global Pneumococcal Polysaccharide Vaccine Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Children (2-10 Age)
        • 1.3.3 Adult (10-64 Age)
        • 1.3.4 Geriatric (More Than 65 Age)
      • 1.4 Global Pneumococcal Polysaccharide Vaccine Overall Market
        • 1.4.1 Global Pneumococcal Polysaccharide Vaccine Revenue (2014-2025)
        • 1.4.2 Global Pneumococcal Polysaccharide Vaccine Production (2014-2025)
        • 1.4.3 North America Pneumococcal Polysaccharide Vaccine Status and Prospect (2014-2025)
        • 1.4.4 Europe Pneumococcal Polysaccharide Vaccine Status and Prospect (2014-2025)
        • 1.4.5 China Pneumococcal Polysaccharide Vaccine Status and Prospect (2014-2025)
        • 1.4.6 Japan Pneumococcal Polysaccharide Vaccine Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Pneumococcal Polysaccharide Vaccine Status and Prospect (2014-2025)
        • 1.4.8 India Pneumococcal Polysaccharide Vaccine Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Pneumococcal Polysaccharide Vaccine
      • 2.3 Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine
      • 2.4 Industry Chain Structure of Pneumococcal Polysaccharide Vaccine

      3 Development and Manufacturing Plants Analysis of Pneumococcal Polysaccharide Vaccine

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Pneumococcal Polysaccharide Vaccine Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Pneumococcal Polysaccharide Vaccine
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Pneumococcal Polysaccharide Vaccine Production and Capacity Analysis
      • 4.2 Pneumococcal Polysaccharide Vaccine Revenue Analysis
      • 4.3 Pneumococcal Polysaccharide Vaccine Price Analysis
      • 4.4 Market Concentration Degree

      5 Pneumococcal Polysaccharide Vaccine Regional Market Analysis

      • 5.1 Pneumococcal Polysaccharide Vaccine Production by Regions
        • 5.1.1 Global Pneumococcal Polysaccharide Vaccine Production by Regions
        • 5.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Regions
      • 5.2 Pneumococcal Polysaccharide Vaccine Consumption by Regions
      • 5.3 North America Pneumococcal Polysaccharide Vaccine Market Analysis
        • 5.3.1 North America Pneumococcal Polysaccharide Vaccine Production
        • 5.3.2 North America Pneumococcal Polysaccharide Vaccine Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Pneumococcal Polysaccharide Vaccine Import and Export
      • 5.4 Europe Pneumococcal Polysaccharide Vaccine Market Analysis
        • 5.4.1 Europe Pneumococcal Polysaccharide Vaccine Production
        • 5.4.2 Europe Pneumococcal Polysaccharide Vaccine Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Pneumococcal Polysaccharide Vaccine Import and Export
      • 5.5 China Pneumococcal Polysaccharide Vaccine Market Analysis
        • 5.5.1 China Pneumococcal Polysaccharide Vaccine Production
        • 5.5.2 China Pneumococcal Polysaccharide Vaccine Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Pneumococcal Polysaccharide Vaccine Import and Export
      • 5.6 Japan Pneumococcal Polysaccharide Vaccine Market Analysis
        • 5.6.1 Japan Pneumococcal Polysaccharide Vaccine Production
        • 5.6.2 Japan Pneumococcal Polysaccharide Vaccine Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Pneumococcal Polysaccharide Vaccine Import and Export
      • 5.7 Southeast Asia Pneumococcal Polysaccharide Vaccine Market Analysis
        • 5.7.1 Southeast Asia Pneumococcal Polysaccharide Vaccine Production
        • 5.7.2 Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Pneumococcal Polysaccharide Vaccine Import and Export
      • 5.8 India Pneumococcal Polysaccharide Vaccine Market Analysis
        • 5.8.1 India Pneumococcal Polysaccharide Vaccine Production
        • 5.8.2 India Pneumococcal Polysaccharide Vaccine Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Pneumococcal Polysaccharide Vaccine Import and Export

      6 Pneumococcal Polysaccharide Vaccine Segment Market Analysis (by Type)

      • 6.1 Global Pneumococcal Polysaccharide Vaccine Production by Type
      • 6.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type
      • 6.3 Pneumococcal Polysaccharide Vaccine Price by Type

      7 Pneumococcal Polysaccharide Vaccine Segment Market Analysis (by Application)

      • 7.1 Global Pneumococcal Polysaccharide Vaccine Consumption by Application
      • 7.2 Global Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2014-2019)

      8 Pneumococcal Polysaccharide Vaccine Major Manufacturers Analysis

      • 8.1 Merck & Co., Inc.
        • 8.1.1 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
        • 8.1.2 Merck & Co., Inc. Product Introduction, Application and Specification
        • 8.1.3 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Pfizer Inc.
        • 8.2.1 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
        • 8.2.2 Pfizer Inc. Product Introduction, Application and Specification
        • 8.2.3 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Glaxosmithkline Plc.
        • 8.3.1 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
        • 8.3.2 Glaxosmithkline Plc. Product Introduction, Application and Specification
        • 8.3.3 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Sanofi Pasteur
        • 8.4.1 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
        • 8.4.2 Sanofi Pasteur Product Introduction, Application and Specification
        • 8.4.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 China National Biotec Group
        • 8.5.1 China National Biotec Group Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
        • 8.5.2 China National Biotec Group Product Introduction, Application and Specification
        • 8.5.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Astellas Pharma Inc
        • 8.6.1 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
        • 8.6.2 Astellas Pharma Inc Product Introduction, Application and Specification
        • 8.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Serum Institute of India Pvt. Ltd
        • 8.7.1 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
        • 8.7.2 Serum Institute of India Pvt. Ltd Product Introduction, Application and Specification
        • 8.7.3 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served

      9 Development Trend of Analysis of Pneumococcal Polysaccharide Vaccine Market

      • 9.1 Global Pneumococcal Polysaccharide Vaccine Market Trend Analysis
        • 9.1.1 Global Pneumococcal Polysaccharide Vaccine Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Pneumococcal Polysaccharide Vaccine Regional Market Trend
        • 9.2.1 North America Pneumococcal Polysaccharide Vaccine Forecast 2019-2025
        • 9.2.2 Europe Pneumococcal Polysaccharide Vaccine Forecast 2019-2025
        • 9.2.3 China Pneumococcal Polysaccharide Vaccine Forecast 2019-2025
        • 9.2.4 Japan Pneumococcal Polysaccharide Vaccine Forecast 2019-2025
        • 9.2.5 Southeast Asia Pneumococcal Polysaccharide Vaccine Forecast 2019-2025
        • 9.2.6 India Pneumococcal Polysaccharide Vaccine Forecast 2019-2025
      • 9.3 Pneumococcal Polysaccharide Vaccine Market Trend (Product Type)
      • 9.4 Pneumococcal Polysaccharide Vaccine Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Pneumococcal Polysaccharide Vaccine Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Pneumococcal Polysaccharide Vaccine . Industry analysis & Market Report on Pneumococcal Polysaccharide Vaccine is a syndicated market report, published as Global Pneumococcal Polysaccharide Vaccine Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Pneumococcal Polysaccharide Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,754.50
        4,131.75
        5,509.00
        3,234.00
        4,851.00
        6,468.00
        549,115.00
        823,672.50
        1,098,230.00
        291,550.00
        437,325.00
        583,100.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report